PAPER Takahashi K
SEARCH RESULTS
331743 RESULTS
PAPER Han J, Song QQ, Sun P, Zhang J, Wang X, Song J, Li GQ, Liu YH, Mei GY, Shi Q, Tian C, Chen C, Gao C, Zhao B, Dong XP
Interaction between 14-3-3β and PrP influences the dimerization of 14-3-3 and fibrillization of PrP106-126.
Int J Biochem Cell Biol. 2014 Feb;47:20-8. Epub 2013 Nov 22 PubMed: 24269782PAPER Palma JA, Kaufmann H
Autonomic disorders predicting Parkinson's disease.
Parkinsonism Relat Disord. 2014 Jan;20 Suppl 1:S94-8. PubMed: 24262198PAPER Shi S, Mitteregger-Kretzschmar G, Giese A, Kretzschmar HA
Establishing quantitative real-time quaking-induced conversion (qRT-QuIC) for highly sensitive detection and quantification of PrPSc in prion-infected tissues.
Acta Neuropathol Commun. 2013 Aug 2;1(1):44. PubMed: 24252329PAPER Reiniger L, Mirabile I, Lukic A, Wadsworth JD, Linehan JM, Groves M, Lowe J, Druyeh R, Rudge P, Collinge J, Mead S, Brandner S
Filamentous white matter prion protein deposition is a distinctive feature of multiple inherited prion diseases.
Acta Neuropathol Commun. 2013 May 9;1(1):8. PubMed: 24252267PAPER Kobayashi A, Iwasaki Y, Otsuka H, Yamada M, Yoshida M, Matsuura Y, Mohri S, Kitamoto T
Deciphering the pathogenesis of sporadic Creutzfeldt-Jakob disease with codon 129 M/V and type 2 abnormal prion protein.
Acta Neuropathol Commun. 2013 Nov 13;1(1):74. PubMed: 24252157PAPER Mercer RC, Ma L, Watts JC, Strome R, Wohlgemuth S, Yang J, Cashman NR, Coulthart MB, Schmitt-Ulms G, Jhamandas JH, Westaway D
The prion protein modulates A-type K+ currents mediated by Kv4.2 complexes through dipeptidyl aminopeptidase-like protein 6.
J Biol Chem. 2013 Dec 27;288(52):37241-55. Epub 2013 Nov 13 PubMed: 24225951PAPER Crapeau M, Maillet L, Cullin C
Ploidy controls [URE3] prion propagation in yeast.
FEMS Yeast Res. 2013 Oct 12; PubMed: 24205798PAPER Pasquereau B, Turner RS
Primary motor cortex of the parkinsonian monkey: altered neuronal responses to muscle stretch.
Front Syst Neurosci. 2013;7:98. Epub 2013 Nov 26 PubMed: 24324412PAPER Senek M, Nyholm D
Continuous drug delivery in Parkinson's disease.
CNS Drugs. 2014 Jan;28(1):19-27. PubMed: 24323838PAPER Borgohain R, Szasz J, Stanzione P, Meshram C, Bhatt M, Chirilineau D, Stocchi F, Lucini V, Giuliani R, Forrest E, Rice P, Anand R, Study 016 Investigators
Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations.
Mov Disord. 2014 Feb;29(2):229-37. Epub 2013 Dec 9 PubMed: 24323641PAPER Cherubini A, Morelli M, Nisticó R, Salsone M, Arabia G, Vasta R, Augimeri A, Caligiuri ME, Quattrone A
Magnetic resonance support vector machine discriminates between Parkinson disease and progressive supranuclear palsy.
Mov Disord. 2014 Feb;29(2):266-9. Epub 2013 Dec 3 PubMed: 24323617PAPER Constantinescu R, Elm J, Auinger P, Sharma S, Augustine EF, Khadim L, Kieburtz K, NET-PD Investigators
Malignant melanoma in early-treated Parkinson's disease: the NET-PD trial.
Mov Disord. 2014 Feb;29(2):263-5. Epub 2013 Dec 3 PubMed: 24323565PAPER Pinna A, Morelli M
A critical evaluation of behavioral rodent models of motor impairment used for screening of antiparkinsonian activity: The case of adenosine A(2A) receptor antagonists.
Neurotox Res. 2014 May;25(4):392-401. Epub 2013 Dec 10 PubMed: 24323318PAPER Milman U, Atias H, Weiss A, Mirelman A, Hausdorff JM
Can cognitive remediation improve mobility in patients with Parkinson's disease? Findings from a 12 week pilot study.
J Parkinsons Dis. 2014;4(1):37-44. PubMed: 24322063Current Filters
No filters selected